Healthcare provider profile · identity verified

Deborah Ann Herrmann, M.D.

Allopathic & Osteopathic Physicians|Family Medicine · MARSHALL, MO · NPI 1508862756

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Deborah Ann Herrmann, M.D. received $110.88 in general payments during 2025 across 4 reported records.

Medtronic, Inc. accounted for 55.5% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 6 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.

Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Nuedexta by this doctor in 2024.

Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Rexulti by this doctor in 2024.

PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 236 claims for Eliquis by this doctor in 2024.

PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Paxlovid by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$110.88

4 reported records · 4 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Medtronic, Inc.	Medtronic, Inc. exact · evidence 2025-07-22	$61.53	55.5%	1	2025
PFIZER INC.	Unresolved — no canonical attribution shown	$19.92	18.0%	1	2025
Insulet Corporation	Unresolved — no canonical attribution shown	$15.84	14.3%	1	2025
Otsuka America Pharmaceutical, Inc.	Unresolved — no canonical attribution shown	$13.59	12.3%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$110.88	4

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
ENDURANT IIS Normalized: endurant iis	Device	Medtronic, Inc.	$61.53	1	2025
Source payment records 2025-09-03 · Medtronic, Inc. · $61.53 · Open Payments source
ABRYSVO Normalized: abrysvo	Biological	PFIZER INC.	$19.92	1	2025
Source payment records 2025-10-02 · PFIZER INC. · $19.92 · Open Payments source
COMIRNATY Normalized: comirnaty	Biological	PFIZER INC.	$19.92	1	2025
Source payment records 2025-10-02 · PFIZER INC. · $19.92 · Open Payments source
PREVNAR 20 Normalized: prevnar 20	Biological	PFIZER INC.	$19.92	1	2025
Source payment records 2025-10-02 · PFIZER INC. · $19.92 · Open Payments source
Omnipod Normalized: omnipod	Device	Insulet Corporation	$15.84	1	2025
Source payment records 2025-06-05 · Insulet Corporation · $15.84 · Open Payments source
REXULTI Normalized: rexulti	Drug	Otsuka America Pharmaceutical, Inc.	$13.59	1	2025
Source payment records 2025-11-12 · Otsuka America Pharmaceutical, Inc. · $13.59 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
REXULTI rexulti	2025	Rexulti	2024	17 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference	2025	NUEDEXTA open payments reported associated product	CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901	Nuedexta · 2024 Exact normalized brand match · 1 Part D row	12	suppressed by CMS
Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference	2025	REXULTI open payments reported associated product	CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708	Rexulti · 2024 Exact normalized brand match · 1 Part D row	17	suppressed by CMS
PFIZER INC. Exact reporting entity; no affiliate inference	2025	ELIQUIS open payments reported associated product	CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063	Eliquis · 2024 Exact normalized brand match · 1 Part D row	236	38
PFIZER INC. Exact reporting entity; no affiliate inference	2025	PAXLOVID open payments reported associated product	CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432	Paxlovid · 2024 Exact normalized brand match · 1 Part D row	11	11

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	768	149
Amlodipine Besylate	Amlodipine Besylate	612	107
Levothyroxine Sodium	Levothyroxine Sodium	529	93
Pantoprazole Sodium	Pantoprazole Sodium	496	91
Furosemide	Furosemide	480	88
Lisinopril	Lisinopril	478	90
Gabapentin	Gabapentin	401	69
Potassium Chloride	Potassium Chloride	392	75
Losartan Potassium	Losartan Potassium	382	66
Omeprazole	Omeprazole	352	83
Sertraline Hcl	Sertraline Hcl	307	46
Albuterol Sulfate Hfa	Albuterol Sulfate	294	83
Trazodone Hcl	Trazodone Hcl	279	51
Metoprolol Succinate	Metoprolol Succinate	274	56
Tramadol Hcl	Tramadol Hcl	250	58
Eliquis	Apixaban	236	38
Metoprolol Tartrate	Metoprolol Tartrate	233	53
Duloxetine Hcl	Duloxetine Hcl	219	33
Metformin Hcl	Metformin Hcl	217	44
Carvedilol	Carvedilol	216	36
Hydrochlorothiazide	Hydrochlorothiazide	211	49
Meloxicam	Meloxicam	187	28
Hydroxyzine Hcl	Hydroxyzine Hcl	178	36
Donepezil Hcl	Donepezil Hcl	171	29
Quetiapine Fumarate	Quetiapine Fumarate	156	16
Tamsulosin Hcl	Tamsulosin Hcl	149	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	147	22
Simvastatin	Simvastatin	146	24
Glimepiride	Glimepiride	145	26
Montelukast Sodium	Montelukast Sodium	145	29
Citalopram Hbr	Citalopram Hydrobromide	141	30
Buspirone Hcl	Buspirone Hcl	139	26
Xarelto	Rivaroxaban	137	15
Warfarin Sodium	Warfarin Sodium	130	suppressed
Benazepril Hcl	Benazepril Hcl	119	25
Clopidogrel	Clopidogrel Bisulfate	118	27
Allopurinol	Allopurinol	117	26
Oxycodone Hcl	Oxycodone Hcl	115	14
Fluticasone Propionate	Fluticasone Propionate	113	37
Rosuvastatin Calcium	Rosuvastatin Calcium	112	31
Tizanidine Hcl	Tizanidine Hcl	108	19
Fluoxetine Hcl	Fluoxetine Hcl	102	16
Ropinirole Hcl	Ropinirole Hcl	102	16
Spironolactone	Spironolactone	99	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	98	22
Baclofen	Baclofen	97	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	90	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	89	14
Ozempic	Semaglutide	88	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	86	24
Diltiazem 24hr Er	Diltiazem Hcl	86	11
Levetiracetam	Levetiracetam	85	12
Memantine Hcl	Memantine Hcl	85	14
Olanzapine	Olanzapine	82	suppressed
Ondansetron Hcl	Ondansetron Hcl	79	36
Amitriptyline Hcl	Amitriptyline Hcl	78	14
Prednisone	Prednisone	78	16
Sucralfate	Sucralfate	76	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	73	13
Ibuprofen	Ibuprofen	73	19
Lamotrigine	Lamotrigine	72	11
Mirtazapine	Mirtazapine	72	15
Famotidine	Famotidine	71	18
Risperidone	Risperidone	68	suppressed
Clonazepam	Clonazepam	67	suppressed
Propranolol Hcl	Propranolol Hcl	67	suppressed
Jardiance	Empagliflozin	66	suppressed
Pregabalin	Pregabalin	65	14
Ezetimibe	Ezetimibe	64	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	64	14
Carbidopa-Levodopa	Carbidopa/Levodopa	63	12
Metformin Hcl Er	Metformin Hcl	62	17
Arexvy	Rsvpref3 Antigen/As01e/Pf	60	60
Lorazepam	Lorazepam	59	19
Aripiprazole	Aripiprazole	57	suppressed
Alprazolam	Alprazolam	56	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	55	12
Methylprednisolone	Methylprednisolone	55	44
Linzess	Linaclotide	53	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	51	14
Alendronate Sodium	Alendronate Sodium	49	18
Escitalopram Oxalate	Escitalopram Oxalate	49	12
Ventolin Hfa	Albuterol Sulfate	45	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	44	31
Divalproex Sodium	Divalproex Sodium	44	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	43	suppressed
Celecoxib	Celecoxib	43	17
Pioglitazone Hcl	Pioglitazone Hcl	42	suppressed
Torsemide	Torsemide	42	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	suppressed
Glipizide	Glipizide	40	suppressed
Azithromycin	Azithromycin	39	37
Brilinta	Ticagrelor	39	suppressed
Divalproex Sodium Er	Divalproex Sodium	39	suppressed
Finasteride	Finasteride	38	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	38	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Diclofenac Sodium	Diclofenac Sodium	37	15
Triamcinolone Acetonide	Triamcinolone Acetonide	37	19
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	13
Symbicort	Budesonide/Formoterol Fumarate	35	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	suppressed
Methenamine Hippurate	Methenamine Hippurate	34	suppressed
Pravastatin Sodium	Pravastatin Sodium	34	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	33	suppressed
Topiramate	Topiramate	33	suppressed
Glycopyrrolate	Glycopyrrolate	32	suppressed
Belsomra	Suvorexant	31	suppressed
Clonidine Hcl	Clonidine Hcl	31	suppressed
Nitroglycerin	Nitroglycerin	31	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	29	14
Lovastatin	Lovastatin	29	suppressed
Amiodarone Hcl	Amiodarone Hcl	28	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	28	11
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Levofloxacin	Levofloxacin	28	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	20
Albuterol Sulfate	Albuterol Sulfate	27	14
Lacosamide	Lacosamide	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	20
Bupropion Xl	Bupropion Hcl	26	suppressed
Entresto	Sacubitril/Valsartan	26	suppressed
Cephalexin	Cephalexin	25	12
Methocarbamol	Methocarbamol	25	suppressed
Ranolazine Er	Ranolazine	25	suppressed
Tradjenta	Linagliptin	25	suppressed
Valsartan	Valsartan	25	suppressed
Water	Water For Irrigation,sterile	25	suppressed
Amantadine	Amantadine Hcl	24	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	24	suppressed
Ondansetron Odt	Ondansetron	24	14
Silodosin	Silodosin	24	suppressed
Terazosin Hcl	Terazosin Hcl	24	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Amoxicillin	Amoxicillin	23	17
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	suppressed
Cefdinir	Cefdinir	23	14
Doxycycline Hyclate	Doxycycline Hyclate	23	11
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	23	suppressed
Novolog Flexpen	Insulin Aspart	23	11
Atenolol	Atenolol	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Nyamyc	Nystatin	21	14
Movantik	Naloxegol Oxalate	20	suppressed
Nystatin	Nystatin	20	17
Prazosin Hcl	Prazosin Hcl	20	suppressed
Primidone	Primidone	20	suppressed
Diltiazem Hcl	Diltiazem Hcl	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Colestipol Hcl	Colestipol Hcl	18	suppressed
Fentanyl	Fentanyl	18	suppressed
Fluconazole	Fluconazole	18	16
Lansoprazole	Lansoprazole	18	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Levemir Flexpen	Insulin Detemir	18	suppressed
Methimazole	Methimazole	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Aimovig Autoinjector	Erenumab-Aooe	17	suppressed
Dutasteride	Dutasteride	17	suppressed
Memantine Hcl Er	Memantine Hcl	17	suppressed
Nebivolol Hcl	Nebivolol Hcl	17	suppressed
Rexulti	Brexpiprazole	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Clonidine	Clonidine	16	suppressed
Estradiol	Estradiol	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Budesonide	Budesonide	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Naproxen	Naproxen	15	suppressed
Nystop	Nystatin	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Phenobarbital	Phenobarbital	15	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	15	suppressed
Creon	Lipase/Protease/Amylase	14	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Letrozole	Letrozole	14	suppressed
Loxapine	Loxapine Succinate	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Arformoterol Tartrate	Arformoterol Tartrate	13	suppressed
Atrovent Hfa	Ipratropium Bromide	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	13	suppressed
Diazepam	Diazepam	13	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	13	suppressed
Phenytoin	Phenytoin	13	suppressed
Potassium Citrate Er	Potassium Citrate	13	suppressed
Temazepam	Temazepam	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Techlite Pen Needle	Pen Needle, Diabetic	12	suppressed
Admelog Solostar	Insulin Lispro	11	suppressed
Cetirizine Hcl	Cetirizine Hcl	11	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Repatha Sureclick	Evolocumab	11	suppressed
Roflumilast	Roflumilast	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$110.88 · 4 records	Medtronic, Inc.	ABRYSVO, COMIRNATY, ENDURANT IIS, Omnipod, PREVNAR 20, REXULTI	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Rexulti play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Otsuka America Pharmaceutical, Inc.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error